| http://www.w3.org/ns/prov#value | - t ISIS-PTP1BRx has the potential to be broadly useful in combination with most of the other commonly used drugs to treat patients with diabetes, including insulin, glucagon-like peptide (GLP-1) agonists, and more traditional drugs like metformin.
|
